Venetoclax for the treatment of translocation (11;14) AL amyloidosisM Hasib Sidiqi, Prashant Kapoor, Abdullah S. Al Saleh et al.|Blood Cancer Journal|2020Cited by 54
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myelomaMohammed A. Aljama, Shaji Kumar, Angela Dispenzieri et al.|Blood Advances|2018Cited by 32
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantationM Hasib Sidiqi, Morie A. Gertz, Mohammed A. Aljama et al.|Blood Advances|2018Cited by 28
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myelomaMohammed A. Aljama, Shaji Kumar, M Hasib Sidiqi et al.|American Journal of Hematology|2018Cited by 27
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myelomaM Hasib Sidiqi, Morie A. Gertz, Mohammed A. Aljama et al.|Blood Cancer Journal|2018Cited by 20